Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vericel Corp (NASDAQ:VCEL)

4.20
Delayed Data
As of Oct 20
 -0.30 / -6.67%
Today’s Change
2.00
Today|||52-Week Range
6.30
+40.00%
Year-to-Date
No recent news for Vericel Corp.

Today’s Trading

Previous close4.50
Today’s open4.50
Day’s range4.20 - 4.55
Volume723,001
Average volume (3 months)645,079
Market cap$137.9M
Dividend yield--
Data as of 10/20/2017

Growth & Valuation

Earnings growth (last year)-21.65%
Earnings growth (this year)+47.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+6.28%
P/E ratioNM
Price/Sales1.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
MDWDMediwound Ltd-0.10-1.96%
MRTXMirati Therapeutics ...+0.20+1.29%
--Verona Pharma PLC-0.05-3.22%
REPHRecro Pharma Inc+0.02+0.22%
Data as of 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$54.4M
Annual profit (last year)-$19.6M
Net profit margin-35.98%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Dominick C. Colangelo
Chief Operating Officer
Daniel R. Orlando
Corporate headquarters
Cambridge, Massachusetts

Forecasts